Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.14 trillion and total revenue of $109.89 billion.
Market Cap
1.14T
Revenue
109.89B
Profits
-41.33B
PE Ratio
n/a
Profit Margin
-37.61%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.49B | 1.28% | 1,524,291 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 61.85B | -1.11% | 1,299,691 | 14.92B |
| 3 | ARGX | argenx SE | 56.24B | 1.57% | 259,526 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.75B | 0.29% | 1,322,217 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 33.54B | 0.76% | 2,227,787 | - |
| 6 | RPRX | Royalty Pharma plc | 30.92B | -0.94% | 3,145,669 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 29.20B | -0.47% | 364,260 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 24.52B | 11.55% | 12,447,970 | 2.23B |
| 9 | BNTX | BioNTech SE | 23.32B | 3.04% | 902,500 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 22.44B | 2.60% | 7,849,172 | 8.26M |
| 11 | INSM | Insmed Incorporated | 21.34B | 3.07% | 3,472,922 | 819.56M |
| 12 | INCY | Incyte Corporation | 19.78B | -0.76% | 1,716,060 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.60B | 2.63% | 2,438,824 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.36B | -0.02% | 726,647 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.24B | 0.02% | 680,038 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.20B | 1.13% | 1,601,502 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.18B | 0.65% | 2,016,149 | 2.38B |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.98B | 0.10% | 519,447 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.28B | 1.67% | 1,788,352 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.52B | -0.27% | 273,216 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.42B | 5.87% | 3,099,969 | 622.01M |
| 22 | SMMT | Summit Therapeutics Inc. | 10.92B | 1.37% | 5,961,601 | - |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.63B | -0.18% | 1,739,045 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 10.61B | 3.86% | 3,340,446 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 10.07B | 5.66% | 514,696 | 417.30M |
| 26 | NUVL | Nuvalent, Inc. | 9.75B | -0.02% | 4,844,336 | - |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.78B | -2.34% | 850,651 | 769.10M |
| 28 | TECH | Bio-Techne Corporation | 8.61B | -1.84% | 2,347,234 | 1.21B |
| 29 | ABVX | ABIVAX Société Anonyme | 8.16B | 2.72% | 1,731,309 | 5.67M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.13B | -1.54% | 1,566,624 | 1.51B |
| 31 | SYRE | Spyre Therapeutics, Inc. | 7.60B | 4.89% | 1,537,190 | - |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.53B | 4.96% | 473,607 | 7.46M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.39B | 2.81% | 1,092,512 | 51.48M |
| 34 | IBRX | ImmunityBio, Inc. | 7.32B | 4.02% | 13,199,303 | 140.98M |
| 35 | PCVX | Vaxcyte, Inc. | 7.32B | 2.76% | 1,117,557 | - |
| 36 | TGTX | TG Therapeutics, Inc. | 7.30B | 1.90% | 3,616,109 | 700.35M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 7.17B | 0.72% | 742,535 | 74.06M |
| 38 | IMVT | Immunovant, Inc. | 7.13B | 3.27% | 1,770,159 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.63B | 3.74% | 1,223,821 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.57B | 6.81% | 1,741,357 | 217.17M |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.51B | 7.18% | 3,183,591 | 827.11M |
| 42 | LEGN | Legend Biotech Corporation | 6.23B | 0.42% | 1,058,200 | 1.14B |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.22B | 0.48% | 1,966,068 | 569.61M |
| 44 | CNTA | Centessa Pharmaceuticals plc | 6.17B | 0.30% | 2,943,860 | 15.00M |
| 45 | BLTE | Belite Bio, Inc | 5.84B | 7.34% | 332,999 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 5.75B | 1.81% | 2,067,975 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.63B | 3.05% | 1,190,135 | - |
| 48 | CGON | CG Oncology, Inc. | 5.33B | 0.25% | 873,600 | 5.07M |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.27B | 3.09% | 354,977 | 274.48M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.14B | 2.33% | 1,155,327 | 7.50M |
| 51 | CRSP | CRISPR Therapeutics AG | 5.12B | 2.06% | 2,097,505 | 4.10M |
| 52 | CAI | Caris Life Sciences, Inc. | 5.05B | -0.67% | 2,349,846 | 907.29M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.03B | 1.42% | 1,348,024 | 536.20M |
| 54 | TNGX | Tango Therapeutics, Inc. | 4.67B | 0.40% | 2,819,406 | 56.99M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.48B | 3.82% | 870,342 | 1.34M |
| 56 | ERAS | Erasca, Inc. | 4.35B | 4.48% | 4,491,248 | - |
| 57 | CELC | Celcuity Inc. | 4.29B | 0.84% | 1,212,278 | - |
| 58 | ORKA | Oruka Therapeutics, Inc. | 4.27B | 4.68% | 769,911 | - |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.16% | 2,868,493 | 596.96M |
| 60 | MANE | Veradermics, Incorporated | 3.84B | 1.01% | 415,290 | - |
| 61 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.77B | 2.14% | 743,919 | 18.07M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.75B | 2.56% | 3,098,789 | - |
| 63 | DNLI | Denali Therapeutics Inc. | 3.73B | 7.11% | 2,605,206 | - |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | 3.15% | 1,340,345 | 1.10B |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.52B | -0.13% | 954,298 | 22.57M |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.52B | 2.16% | 1,887,679 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.44B | 3.76% | 162,151 | 803.79M |
| 68 | RLAY | Relay Therapeutics, Inc. | 3.39B | 3.39% | 2,863,674 | 10.68M |
| 69 | PBLS | Parabilis Medicines, Inc. | 3.31B | -2.11% | 1,929,249 | - |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | 2.14% | 1,625,102 | 415.62M |
| 71 | BEAM | Beam Therapeutics Inc. | 3.23B | 4.81% | 2,174,740 | 164.01M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.20B | 4.87% | 1,028,298 | - |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.17B | 6.25% | 3,452,721 | - |
| 74 | QURE | uniQure N.V. | 3.04B | 78.44% | 19,709,008 | 18.09M |
| 75 | RCUS | Arcus Biosciences, Inc. | 3.03B | 2.42% | 920,380 | 236.00M |
| 76 | ALMS | Alumis Inc. | 2.94B | 3.27% | 1,423,531 | 8.40M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 2.75B | 2.26% | 937,775 | 225.27M |
| 78 | ELVN | Enliven Therapeutics, Inc. | 2.73B | 5.43% | 1,505,907 | - |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | 2.88% | 462,278 | 535.08M |
| 80 | IRON | Disc Medicine, Inc. | 2.68B | 0.54% | 692,514 | - |
| 81 | DFTX | Definium Therapeutics, Inc. | 2.66B | 1.12% | 1,583,193 | - |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | 8.29% | 3,242,964 | 670.00M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.58B | 1.89% | 991,671 | 865.00K |
| 84 | VERA | Vera Therapeutics, Inc. | 2.51B | 3.98% | 1,122,307 | - |
| 85 | KLRA | Kailera Therapeutics, Inc. | 2.48B | 3.13% | 746,879 | - |
| 86 | PHVS | Pharvaris N.V. | 2.33B | 6.20% | 287,421 | - |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.32B | 6.30% | 2,675,897 | - |
| 88 | KOD | Kodiak Sciences Inc. | 2.23B | 8.41% | 886,017 | - |
| 89 | NTLA | Intellia Therapeutics, Inc. | 2.12B | 4.47% | 12,427,239 | 66.09M |
| 90 | OCUL | Ocular Therapeutix, Inc. | 2.11B | 7.83% | 7,403,977 | 52.04M |
| 91 | IMNM | Immunome, Inc. | 2.10B | 3.46% | 1,419,683 | 4.02M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | -0.49% | 818,397 | 298.30M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | 4.75% | 1,646,411 | - |
| 94 | NKTR | Nektar Therapeutics | 2.06B | 1.08% | 676,732 | 55.63M |
| 95 | BHVN | Biohaven Ltd. | 2.05B | 12.66% | 6,982,351 | - |
| 96 | ZLAB | Zai Lab Limited | 2.01B | 0.85% | 1,011,607 | 453.28M |
| 97 | VCEL | Vericel Corporation | 2.00B | 1.74% | 777,644 | 292.09M |
| 98 | MBX | MBX Biosciences, Inc. | 1.98B | 3.74% | 676,980 | - |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | 3.89% | 920,521 | 66.05M |
| 100 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | -0.18% | 626,918 | 899.11M |
| 101 | ADMA | ADMA Biologics, Inc. | 1.95B | -1.86% | 3,223,363 | 509.86M |
| 102 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 0.67% | 125,293 | 1.20B |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.88B | 3.81% | 955,162 | 32.08M |
| 104 | NUVB | Nuvation Bio Inc. | 1.86B | 4.10% | 5,416,904 | 143.05M |
| 105 | VRDN | Viridian Therapeutics, Inc. | 1.85B | 4.57% | 2,030,808 | 70.92M |
| 106 | MESO | Mesoblast Limited | 1.81B | 1.60% | 151,432 | 65.38M |
| 107 | NBTX | Nanobiotix S.A. | 1.80B | 0.22% | 74,207 | 38.27M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 7.48% | 4,512,853 | 2.18B |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 1.78B | 5.81% | 2,274,394 | 7.47M |
| 110 | GENB | Generate Biomedicines, Inc. | 1.78B | 3.74% | 802,113 | 30.30M |
| 111 | NRIX | Nurix Therapeutics, Inc. | 1.77B | 0.29% | 2,514,281 | 71.78M |
| 112 | RAPP | Rapport Therapeutics, Inc. | 1.76B | -4.21% | 273,473 | 20.00M |
| 113 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | 2.88% | 11,208,026 | 285.61M |
| 114 | TYRA | Tyra Biosciences, Inc. | 1.73B | 3.05% | 743,999 | - |
| 115 | ZYME | Zymeworks Inc. | 1.69B | 2.89% | 697,677 | 81.26M |
| 116 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | 2.64% | 1,900,539 | 217.17M |
| 117 | PGEN | Precigen, Inc. | 1.69B | -0.42% | 3,834,277 | 31.60M |
| 118 | INVA | Innoviva, Inc. | 1.67B | 0.13% | 588,385 | 420.69M |
| 119 | ABCL | AbCellera Biologics Inc. | 1.66B | 6.88% | 5,645,750 | 79.21M |
| 120 | SION | Sionna Therapeutics, Inc. | 1.66B | 5.70% | 406,686 | - |
| 121 | ANAB | AnaptysBio, Inc. | 1.65B | -1.46% | 603,716 | 232.39M |
| 122 | RXRX | Recursion Pharmaceuticals, Inc. | 1.65B | -2.20% | 22,173,126 | 66.41M |
| 123 | CAPR | Capricor Therapeutics, Inc. | 1.62B | 7.29% | 1,460,392 | 11.13M |
| 124 | PVLA | Palvella Therapeutics, Inc. | 1.62B | 2.28% | 181,858 | - |
| 125 | SEPN | Septerna, Inc. | 1.61B | 1.79% | 325,299 | 72.26M |
| 126 | URGN | UroGen Pharma Ltd. | 1.60B | 2.69% | 547,701 | 140.49M |
| 127 | VIR | Vir Biotechnology, Inc. | 1.57B | 8.01% | 3,000,584 | 65.50M |
| 128 | NVAX | Novavax, Inc. | 1.56B | 3.26% | 3,901,672 | 596.34M |
| 129 | GLUE | Monte Rosa Therapeutics, Inc. | 1.56B | 3.66% | 1,184,533 | 42.95M |
| 130 | AAPG | Ascentage Pharma Group International | 1.54B | 0.47% | 15,117 | 82.08M |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.51B | 4.42% | 609,625 | - |
| 132 | ATAI | AtaiBeckley Inc. | 1.50B | -1.69% | 3,979,038 | 3.49M |
| 133 | GHRS | GH Research PLC | 1.49B | 8.61% | 178,554 | - |
| 134 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 3.40% | 529,077 | - |
| 135 | IMCR | Immunocore Holdings plc | 1.45B | 1.35% | 683,075 | 412.81M |
| 136 | FTRE | Fortrea Holdings Inc. | 1.45B | -4.13% | 1,087,244 | 2.71B |
| 137 | SLS | SELLAS Life Sciences Group, Inc. | 1.44B | 3.05% | 4,681,749 | - |
| 138 | ARDX | Ardelyx, Inc. | 1.44B | 3.00% | 3,424,545 | 427.68M |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.41B | 1.11% | 878,842 | - |
| 140 | INBX | Inhibrx Biosciences, Inc. | 1.38B | 1.17% | 269,197 | 1.30M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.37B | 4.11% | 473,980 | 20.00M |
| 142 | SVRA | Savara Inc. | 1.36B | 1.51% | 1,392,920 | - |
| 143 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.35B | 4.19% | 1,920,382 | 204.73M |
| 144 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 7.55% | 410,719 | - |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.32B | 4.03% | 259,080 | - |
| 146 | IMTX | Immatics N.V. | 1.30B | 4.73% | 292,980 | 43.00M |
| 147 | AKTS | Aktis Oncology, Inc. | 1.30B | 3.98% | 523,598 | 8.28M |
| 148 | AVLN | Avalyn Pharma Inc. | 1.23B | 4.42% | 543,614 | - |
| 149 | MNKD | MannKind Corporation | 1.21B | 1.29% | 3,665,280 | 360.78M |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.17B | 2.14% | 602,752 | 10.00M |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.17B | 3.68% | 372,565 | - |
| 152 | WVE | Wave Life Sciences Ltd. | 1.14B | 3.66% | 5,190,012 | 71.80M |
| 153 | ABSI | Absci Corporation | 1.12B | 2.57% | 6,358,722 | 1.84M |
| 154 | EYPT | EyePoint, Inc. | 1.10B | 2.10% | 1,180,462 | 7.61M |
| 155 | SLBT | SL Science Holding Limited | 1.03B | -28.23% | 1,404,200 | - |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.01B | 2.21% | 1,171,644 | - |
| 157 | JBIO | Jade Biosciences, Inc. | 1.00B | 8.63% | 738,111 | - |
| 158 | DBVT | DBV Technologies S.A. | 998.84M | -2.81% | 225,078 | 5.74M |
| 159 | SPRY | ARS Pharmaceuticals, Inc. | 983.10M | 2.06% | 1,018,637 | 98.99M |
| 160 | MGTX | MeiraGTx Holdings plc | 964.07M | 7.21% | 1,013,899 | 79.76M |
| 161 | XNCR | Xencor, Inc. | 947.53M | 4.75% | 1,051,848 | 97.36M |
| 162 | PHAR | Pharming Group N.V. | 923.03M | 1.12% | 1,839 | 369.49M |
| 163 | SPTX | Seaport Therapeutics, Inc. | 915.37M | -4.84% | 259,295 | - |
| 164 | SANA | Sana Biotechnology, Inc. | 911.69M | 7.42% | 6,254,569 | - |
| 165 | LXRX | Lexicon Pharmaceuticals, Inc. | 906.16M | 4.62% | 2,622,399 | 69.64M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 893.36M | 3.85% | 1,434,536 | - |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 887.45M | 6.57% | 1,527,526 | - |
| 168 | ABUS | Arbutus Biopharma Corporation | 875.09M | 0.91% | 2,031,638 | 191.45M |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 873.73M | 5.47% | 860,701 | 204.89M |
| 170 | ODTX | Odyssey Therapeutics, Inc. | 871.78M | 3.41% | 471,203 | 2.98M |
| 171 | DRTS | Alpha Tau Medical Ltd. | 866.59M | 2.78% | 482,660 | - |
| 172 | JANX | Janux Therapeutics, Inc. | 862.93M | 3.28% | 1,931,846 | 13.73M |
| 173 | LBRX | LB Pharmaceuticals Inc | 861.73M | 8.64% | 334,451 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 861.45M | 0.12% | 424,380 | 109.78M |
| 175 | KURA | Kura Oncology, Inc. | 849.57M | 1.81% | 1,804,079 | 71.64M |
| 176 | REPL | Replimune Group, Inc. | 825.73M | 13.90% | 4,316,730 | - |
| 177 | OLMA | Olema Pharmaceuticals, Inc. | 824.56M | 2.72% | 1,733,719 | - |
| 178 | VOR | Vor Biopharma Inc. | 813.87M | 6.45% | 1,110,362 | - |
| 179 | AVTX | Avalo Therapeutics, Inc. | 809.51M | 7.47% | 1,165,483 | 59.00K |
| 180 | ANNX | Annexon, Inc. | 809.38M | 9.29% | 2,376,527 | - |
| 181 | GERN | Geron Corporation | 789.07M | 4.24% | 13,869,370 | 196.12M |
| 182 | ANRO | Alto Neuroscience, Inc. | 764.70M | 3.76% | 272,799 | - |
| 183 | IVA | Inventiva S.A. | 751.19M | -1.40% | 1,033,906 | 7.94M |
| 184 | ZVRA | Zevra Therapeutics, Inc. | 745.44M | -0.32% | 1,381,972 | 122.29M |
| 185 | DSGN | Design Therapeutics, Inc. | 745.11M | 11.29% | 1,021,731 | - |
| 186 | EVMN | Evommune, Inc. | 743.78M | 2.99% | 602,898 | 10.00M |
| 187 | SLDB | Solid Biosciences Inc. | 719.67M | 3.39% | 3,405,271 | - |
| 188 | TENX | Tenax Therapeutics, Inc. | 698.89M | 4.77% | 1,280,545 | - |
| 189 | OMER | Omeros Corporation | 697.70M | 1.69% | 1,417,148 | 9.89M |
| 190 | AURA | Aura Biosciences, Inc. | 695.99M | 0.48% | 531,094 | - |
| 191 | RLMD | Relmada Therapeutics, Inc. | 692.28M | 0.76% | 1,358,724 | - |
| 192 | OCS | Oculis Holding AG | 682.39M | -1.31% | 581,064 | 1.40M |
| 193 | CRMD | CorMedix Inc. | 680.18M | 0.12% | 1,189,005 | 400.05M |
| 194 | ALLO | Allogene Therapeutics, Inc. | 676.50M | 3.16% | 6,362,246 | 22.00K |
| 195 | IMMX | Immix Biopharma, Inc. | 649.96M | 4.46% | 1,963,449 | - |
| 196 | CLYM | Climb Bio, Inc. | 649.33M | 5.88% | 906,917 | - |
| 197 | CTMX | CytomX Therapeutics, Inc. | 644.40M | 1.02% | 5,519,809 | 35.54M |
| 198 | TRAX | First Tracks Biotherapeutics, Inc. | 633.99M | 6.01% | 734,367 | - |
| 199 | RIGL | Rigel Pharmaceuticals, Inc. | 617.41M | 2.80% | 264,172 | 299.77M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 617.31M | 1.84% | 1,187,760 | 8.37M |
| 201 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 615.22M | -0.65% | 557,272 | - |
| 202 | SGP | SpyGlass Pharma, Inc. | 608.36M | 3.64% | 108,919 | - |
| 203 | CBIO | Crescent Biopharma, Inc. | 605.10M | 1.45% | 382,005 | 11.88M |
| 204 | DRUG | Bright Minds Biosciences Inc. | 592.58M | -0.50% | 152,610 | - |
| 205 | CADL | Candel Therapeutics, Inc. | 585.43M | 0.25% | 1,373,697 | - |
| 206 | PRME | Prime Medicine, Inc. | 570.75M | 10.10% | 4,211,334 | 4.03M |
| 207 | TECX | Tectonic Therapeutic, Inc. | 567.21M | 0.17% | 190,391 | - |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 558.52M | 4.14% | 1,176,248 | 151.40M |
| 209 | GYRE | Gyre Therapeutics, Inc. | 555.54M | 4.47% | 66,354 | 117.05M |
| 210 | ACHV | Achieve Life Sciences, Inc. | 550.25M | -3.42% | 1,664,883 | - |
| 211 | MDXG | MiMedx Group, Inc. | 537.69M | -2.43% | 998,781 | 389.42M |
| 212 | PROK | ProKidney Corp. | 528.60M | 3.55% | 755,692 | 889.00K |
| 213 | EIKN | Eikon Therapeutics, Inc. | 526.77M | 7.28% | 265,706 | - |
| 214 | XOMA | XOMA Royalty Corporation | 523.21M | -0.14% | 80,470 | 48.56M |
| 215 | ALT | Altimmune, Inc. | 513.41M | 0.76% | 3,570,898 | 36.00K |
| 216 | VALN | Valneva SE | 511.98M | -0.19% | 10,426 | 180.25M |
| 217 | INDP | Indaptus Therapeutics, Inc. | 509.59M | 20.97% | 749,137 | - |
| 218 | RZLT | Rezolute, Inc. | 500.40M | 4.81% | 3,081,730 | - |
| 219 | AGMB | AgomAb Therapeutics NV | 497.40M | 1.00% | 116,748 | - |
| 220 | ARVN | Arvinas, Inc. | 494.88M | 3.37% | 638,617 | 89.40M |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 492.44M | 8.65% | 962,824 | 88.24M |
| 222 | KYTX | Kyverna Therapeutics, Inc. | 486.66M | 1.52% | 811,543 | - |
| 223 | NGNE | Neurogene Inc. | 486.54M | 4.91% | 250,998 | 925.00K |
| 224 | ARTV | Artiva Biotherapeutics, Inc. | 482.97M | 11.56% | 952,270 | 251.00K |
| 225 | ASMB | Assembly Biosciences, Inc. | 478.59M | 3.51% | 133,828 | 71.10M |
| 226 | STRO | Sutro Biopharma, Inc. | 470.77M | 0.85% | 499,888 | 99.61M |
| 227 | CABA | Cabaletta Bio, Inc. | 463.08M | 1.43% | 5,139,474 | - |
| 228 | CTNM | Contineum Therapeutics, Inc. | 454.62M | -1.94% | 200,884 | - |
| 229 | OVID | Ovid Therapeutics Inc. | 451.67M | 2.54% | 3,863,517 | 7.12M |
| 230 | PRTA | Prothena Corporation plc | 444.48M | 2.41% | 542,968 | 57.94M |
| 231 | CCCC | C4 Therapeutics, Inc. | 433.42M | 2.08% | 2,094,680 | 34.86M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 431.42M | 3.57% | 317,740 | 16.72M |
| 233 | MNPR | Monopar Therapeutics Inc. | 431.33M | 3.27% | 122,971 | - |
| 234 | FBRX | Forte Biosciences, Inc. | 429.82M | 2.57% | 156,129 | - |
| 235 | VTVT | vTv Therapeutics Inc. | 420.93M | 5.21% | 78,192 | 36.84M |
| 236 | OCGN | Ocugen, Inc. | 416.38M | 4.24% | 6,326,911 | 4.47M |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.73M | 4.31% | 435,302 | - |
| 238 | ANL | Adlai Nortye Ltd. | 410.40M | 2.09% | 82,335 | 5.00M |
| 239 | RGNX | REGENXBIO Inc. | 408.41M | 14.00% | 4,964,676 | 87.82M |
| 240 | AUTL | Autolus Therapeutics plc | 407.20M | 2.68% | 999,279 | 92.62M |
| 241 | IPSC | Century Therapeutics, Inc. | 405.80M | 3.21% | 959,727 | 109.16M |
| 242 | BNTC | Benitec Biopharma Inc. | 405.38M | 6.31% | 152,198 | - |
| 243 | SGMT | Sagimet Biosciences Inc. | 403.24M | 3.65% | 794,103 | - |
| 244 | EDIT | Editas Medicine, Inc. | 391.33M | 8.05% | 3,230,483 | 38.69M |
| 245 | LXEO | Lexeo Therapeutics, Inc. | 391.04M | 4.84% | 1,421,116 | - |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 381.99M | 0.25% | 403,778 | 9.01M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 369.52M | 4.12% | 2,224,248 | - |
| 248 | CMPX | Compass Therapeutics, Inc. | 369.18M | 4.06% | 3,744,497 | 850.00K |
| 249 | PBYI | Puma Biotechnology, Inc. | 368.00M | 0.84% | 210,072 | 227.18M |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 367.55M | 4.72% | 171,430 | 69.21M |
| 251 | VSTM | Verastem, Inc. | 366.43M | 3.99% | 2,523,135 | 49.59M |
| 252 | STTK | Shattuck Labs, Inc. | 363.47M | 9.47% | 743,545 | 1.00M |
| 253 | VNDA | Vanda Pharmaceuticals Inc. | 358.41M | 4.01% | 853,391 | 217.78M |
| 254 | GLSI | Greenwich LifeSciences, Inc. | 352.13M | 0.46% | 110,671 | - |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 346.52M | 1.64% | 252,289 | - |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 345.05M | 12.86% | 4,537,522 | - |
| 257 | ZURA | Zura Bio Limited | 343.89M | 2.99% | 1,108,051 | - |
| 258 | UPB | Upstream Bio, Inc. | 334.68M | 3.89% | 839,752 | 3.32M |
| 259 | NVCT | Nuvectis Pharma, Inc. | 333.96M | 5.44% | 98,553 | - |
| 260 | IRD | Opus Genetics, Inc. | 330.47M | 4.10% | 1,065,269 | 11.98M |
| 261 | CNXU | Conexeu Sciences Inc. | 329.02M | 3.99% | 61,378 | - |
| 262 | ABEO | Abeona Therapeutics Inc. | 322.02M | - | 2,193,671 | 14.54M |
| 263 | SLN | Silence Therapeutics plc | 319.30M | 0.75% | 341,321 | 839.00K |
| 264 | FENC | Fennec Pharmaceuticals Inc. | 311.94M | 0.22% | 259,976 | 51.00M |
| 265 | LCTX | Lineage Cell Therapeutics, Inc. | 311.62M | 4.17% | 1,392,321 | 14.78M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 308.75M | 0.70% | 184,869 | - |
| 267 | PALI | Palisade Bio, Inc. | 294.67M | -1.12% | 3,952,318 | - |
| 268 | OABI | OmniAb, Inc. | 294.29M | 0.50% | 506,196 | 28.94M |
| 269 | LYEL | Lyell Immunopharma, Inc. | 292.14M | 0.64% | 167,102 | 31.00K |
| 270 | RNAC | Cartesian Therapeutics, Inc. | 290.29M | 9.17% | 604,935 | 1.78M |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 286.31M | 0.60% | 677,003 | 1.00 |
| 272 | ELDN | Eledon Pharmaceuticals, Inc. | 286.02M | 6.32% | 1,485,365 | - |
| 273 | IMRX | Immuneering Corporation | 285.32M | 7.56% | 1,880,075 | - |
| 274 | NMRA | Neumora Therapeutics, Inc. | 283.48M | -1.92% | 5,352,195 | - |
| 275 | BCYC | Bicycle Therapeutics plc | 282.04M | 0.50% | 969,140 | 63.50M |
| 276 | SRZN | Surrozen, Inc. | 279.11M | 5.67% | 246,772 | 7.49M |
| 277 | NAUT | Nautilus Biotechnology, Inc. | 277.03M | 0.46% | 290,992 | - |
| 278 | IVVD | Invivyd, Inc. | 274.34M | 4.42% | 4,336,523 | 55.87M |
| 279 | SABS | SAB Biotherapeutics, Inc. | 271.26M | 5.46% | 712,620 | 114.70K |
| 280 | NAGE | Niagen Bioscience, Inc. | 268.96M | -1.75% | 489,662 | 130.42M |
| 281 | IFRX | InflaRx N.V. | 268.07M | 13.75% | 1,976,965 | 33.82K |
| 282 | ARMP | Armata Pharmaceuticals, Inc. | 259.07M | 3.98% | 33,694 | 5.20M |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 257.69M | 2.84% | 734,686 | 26.87M |
| 284 | MGNX | MacroGenics, Inc. | 251.71M | 2.06% | 649,605 | 157.08M |
| 285 | AVXL | Anavex Life Sciences Corp. | 247.43M | 5.95% | 1,478,033 | - |
| 286 | CNTN | Canton Strategic Holdings, Inc. | 247.11M | 7.27% | 1,385,935 | - |
| 287 | TRDA | Entrada Therapeutics, Inc. | 245.39M | 4.77% | 201,185 | 5.74M |
| 288 | FHTX | Foghorn Therapeutics Inc. | 237.79M | 1.00% | 141,644 | 28.22M |
| 289 | ADAG | Adagene Inc. | 233.24M | 0.57% | 141,927 | 7.67M |
| 290 | FULC | Fulcrum Therapeutics, Inc. | 233.22M | 1.16% | 10,468,296 | 80.00M |
| 291 | NGEN | NervGen Pharma Corp. | 232.58M | 9.50% | 1,207,350 | - |
| 292 | ACIU | AC Immune SA | 232.13M | -1.27% | 180,679 | 4.62M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 231.74M | 0.52% | 270,847 | 32.72M |
| 294 | CLLS | Cellectis S.A. | 231.09M | 0.98% | 4,376 | 75.11M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 230.01M | -3.44% | 26,053 | 18.47M |
| 296 | HELP | Cybin Inc. | 229.16M | 6.76% | 728,579 | - |
| 297 | TARA | Protara Therapeutics, Inc. | 228.75M | 6.82% | 819,998 | - |
| 298 | FATE | Fate Therapeutics, Inc. | 228.46M | 3.16% | 1,668,729 | 6.32M |
| 299 | CDXS | Codexis, Inc. | 225.42M | - | 783,677 | 78.09M |
| 300 | QTTB | Q32 Bio Inc. | 218.91M | 1.25% | 251,504 | 53.74M |
| 301 | VYGR | Voyager Therapeutics, Inc. | 218.73M | 2.55% | 442,390 | 36.49M |
| 302 | HUMA | Humacyte, Inc. | 215.11M | -5.93% | 13,798,547 | 2.02M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 214.97M | 0.24% | 197,567 | 3.93M |
| 304 | CHRS | Coherus Oncology, Inc. | 214.41M | 0.72% | 646,278 | 46.88M |
| 305 | RNA | Atrium Therapeutics, Inc. | 213.48M | -1.03% | 190,259 | 36.68M |
| 306 | KPTI | Karyopharm Therapeutics Inc. | 213.03M | 3.30% | 283,581 | 151.12M |
| 307 | ARCT | Arcturus Therapeutics Holdings Inc. | 209.19M | 3.08% | 379,031 | 54.71M |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 208.69M | 1.20% | 542,174 | 7.15M |
| 309 | KROS | Keros Therapeutics, Inc. | 206.03M | 3.79% | 241,766 | 33.18M |
| 310 | OTLK | Outlook Therapeutics, Inc. | 199.42M | 5.10% | 24,485,106 | 333.14K |
| 311 | LENZ | LENZ Therapeutics, Inc. | 198.79M | -2.76% | 688,989 | 20.99M |
| 312 | NERV | Minerva Neurosciences, Inc. | 195.21M | -4.12% | 196,856 | - |
| 313 | ALXO | ALX Oncology Holdings Inc. | 195.12M | 5.07% | 1,294,433 | - |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 194.48M | 4.90% | 563,679 | 17.56M |
| 315 | IMUX | Immunic, Inc. | 193.43M | 3.57% | 129,812 | - |
| 316 | EQ | Equillium, Inc. | 189.05M | 8.73% | 699,573 | 4.39M |
| 317 | NKTX | Nkarta, Inc. | 188.88M | 0.76% | 555,966 | - |
| 318 | UNCY | Unicycive Therapeutics, Inc. | 188.24M | -1.67% | 1,138,700 | - |
| 319 | CGEN | Compugen Ltd. | 188.22M | -1.97% | 275,729 | 72.66M |
| 320 | MDWD | MediWound Ltd. | 182.50M | 2.38% | 66,380 | 14.48M |
| 321 | GALT | Galectin Therapeutics Inc. | 182.42M | 4.92% | 266,231 | - |
| 322 | NBP | NovaBridge Biosciences | 181.57M | 3.97% | 714,143 | - |
| 323 | TTRX | Turn Therapeutics Inc. | 179.62M | -2.11% | 45,236 | - |
| 324 | MIST | Milestone Pharmaceuticals Inc. | 178.23M | 1.55% | 2,350,739 | 1.78M |
| 325 | YDES | YD Bio Limited | 177.21M | -5.26% | 31,653 | 510.36K |
| 326 | ANTX | AN2 Therapeutics, Inc. | 176.38M | 2.94% | 335,941 | - |
| 327 | PRQR | ProQR Therapeutics N.V. | 175.96M | 9.87% | 913,336 | 15.73M |
| 328 | OKUR | OnKure Therapeutics, Inc. | 173.30M | 0.94% | 328,201 | - |
| 329 | ALEC | Alector, Inc. | 173.20M | 1.30% | 496,016 | 18.42M |
| 330 | IPHA | Innate Pharma S.A. | 171.84M | -0.56% | 13,353 | 10.57M |
| 331 | DTIL | Precision BioSciences, Inc. | 167.71M | 3.01% | 212,647 | 45.07M |
| 332 | KZIA | Kazia Therapeutics Limited | 162.83M | 3.49% | 196,315 | 1.27M |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 162.75M | -1.94% | 604,897 | 76.38M |
| 334 | CRBU | Caribou Biosciences, Inc. | 162.66M | -2.96% | 1,737,019 | 11.20M |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 162.51M | -1.75% | 947,529 | - |
| 336 | KRRO | Korro Bio, Inc. | 159.37M | 3.66% | 143,445 | 3.84M |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 155.11M | 0.53% | 237,810 | 2.00M |
| 338 | TNYA | Tenaya Therapeutics, Inc. | 154.39M | 4.63% | 2,985,566 | 225.00K |
| 339 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 149.15M | 2.16% | 279,018 | - |
| 340 | ENLV | Enlivex Ltd. | 148.97M | -1.94% | 267,485 | - |
| 341 | MOLN | Molecular Partners AG | 148.03M | -0.51% | 5,009 | 856.30K |
| 342 | VRXA | VERAXA Biotech AG | 147.77M | -38.05% | 877,837 | - |
| 343 | ACOG | Alpha Cognition Inc. | 145.45M | 11.15% | 45,427 | 10.83M |
| 344 | NRXP | NRx Pharmaceuticals, Inc. | 144.06M | 0.25% | 889,741 | 2.29M |
| 345 | HURA | TuHURA Biosciences, Inc. | 141.38M | -0.45% | 493,150 | - |
| 346 | ADCT | ADC Therapeutics SA | 141.18M | 11.41% | 2,078,345 | 79.18M |
| 347 | TLSA | Tiziana Life Sciences Ltd | 139.65M | -1.82% | 267,715 | - |
| 348 | GUTS | Fractyl Health, Inc. | 134.85M | 9.54% | 2,401,987 | 3.00K |
| 349 | SPRB | Spruce Biosciences, Inc. | 134.20M | 3.52% | 73,424 | 697.00K |
| 350 | CNTB | Connect Biopharma Holdings Limited | 130.96M | 4.52% | 354,531 | 233.00K |
| 351 | CGTX | Cognition Therapeutics, Inc. | 126.88M | 12.70% | 2,358,570 | - |
| 352 | GNLX | Genelux Corporation | 126.57M | -5.94% | 542,875 | 8.00K |
| 353 | AGEN | Agenus Inc. | 123.26M | -0.67% | 724,048 | 123.87M |
| 354 | SPRO | Spero Therapeutics, Inc. | 122.17M | -23.83% | 11,185,567 | 61.19M |
| 355 | NTHI | NeOnc Technologies Holdings, Inc. | 121.77M | -7.14% | 106,063 | 39.99K |
| 356 | PYXS | Pyxis Oncology, Inc. | 120.38M | 8.57% | 390,138 | 13.86M |
| 357 | MENS | Jyong Biotech Ltd. | 118.77M | - | 182,538 | - |
| 358 | COYA | Coya Therapeutics, Inc. | 117.99M | 4.36% | 322,160 | 7.94M |
| 359 | PEPG | PepGen Inc. | 117.59M | 6.92% | 1,256,339 | - |
| 360 | ENGN | enGene Therapeutics Inc. | 116.56M | -0.57% | 1,305,747 | - |
| 361 | ALPS | Alps Group Inc | 116.15M | -7.50% | 12,160 | 3.74M |
| 362 | ONCY | Oncolytics Biotech Inc. | 111.21M | -1.86% | 1,686,352 | - |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 110.39M | 2.81% | 1,289,180 | - |
| 364 | PLYX | Polaryx Therapeutics, Inc. | 109.36M | 0.87% | 90,557 | - |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 108.25M | 4.12% | 82,457 | - |
| 366 | FBIO | Fortress Biotech, Inc. | 101.98M | 4.78% | 689,378 | 66.16M |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 100.15M | -2.83% | 12,419 | 37.16M |
| 368 | VANI | Vivani Medical, Inc. | 99.17M | -1.71% | 114,228 | - |
| 369 | CBUS | Cibus, Inc. | 98.47M | -1.53% | 246,915 | 3.64M |
| 370 | BDTX | Black Diamond Therapeutics, Inc. | 95.69M | -0.60% | 1,733,504 | 70.00M |
| 371 | CSBR | Champions Oncology, Inc. | 94.71M | -0.87% | 3,120 | 57.95M |
| 372 | SEER | Seer, Inc. | 94.57M | 0.58% | 65,914 | 15.17M |
| 373 | PTHS | Pelthos Therapeutics Inc. | 93.88M | -3.60% | 9,204 | 27.70M |
| 374 | PMN | ProMIS Neurosciences, Inc. | 93.08M | 2.17% | 12,468 | - |
| 375 | ANIX | Anixa Biosciences, Inc. | 91.52M | 3.07% | 245,254 | - |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 90.95M | - | 1,109,161 | 65.34K |
| 377 | ATHE | Alterity Therapeutics Limited | 89.95M | 10.54% | 44,230 | 4.43M |
| 378 | PYPD | PolyPid Ltd. | 87.43M | -2.15% | 24,337 | - |
| 379 | ATRA | Atara Biotherapeutics, Inc. | 87.13M | 0.52% | 122,164 | 23.14M |
| 380 | CUE | Cue Biopharma, Inc. | 87.02M | 11.89% | 86,434 | 32.73M |
| 381 | BMEA | Biomea Fusion, Inc. | 86.76M | 3.45% | 707,917 | - |
| 382 | ELTX | Elicio Therapeutics, Inc. | 86.65M | 70.65% | 51,120,415 | - |
| 383 | ACET | Adicet Bio, Inc. | 85.06M | 4.38% | 244,199 | - |
| 384 | ICCC | ImmuCell Corporation | 84.90M | 0.05% | 29,399 | 29.93M |
| 385 | RLYB | Rallybio Corporation | 84.21M | 0.13% | 36,515 | 858.00K |
| 386 | AARD | Aardvark Therapeutics, Inc. | 83.34M | 2.69% | 87,230 | - |
| 387 | NRXS | NeurAxis, Inc. | 83.10M | - | 106,431 | 4.28M |
| 388 | OKYO | OKYO Pharma Limited | 82.39M | 4.67% | 75,476 | - |
| 389 | LIXT | Lixte Biotechnology Holdings, Inc. | 80.86M | 1.16% | 508,159 | - |
| 390 | CRDF | Cardiff Oncology, Inc. | 80.68M | -6.35% | 1,614,075 | 525.00K |
| 391 | RNTX | Rein Therapeutics Inc. | 80.47M | -8.48% | 749,656 | - |
| 392 | MAIA | MAIA Biotechnology, Inc. | 80.26M | - | 449,587 | - |
| 393 | LONA | LeonaBio, Inc. | 77.31M | 4.44% | 11,966 | - |
| 394 | OSTX | OS Therapies Incorporated | 76.61M | -2.82% | 470,816 | - |
| 395 | RANI | Rani Therapeutics Holdings, Inc. | 76.38M | 0.72% | 556,575 | 3.17M |
| 396 | GANX | Gain Therapeutics, Inc. | 75.92M | -0.56% | 381,736 | - |
| 397 | HYFT | MindWalk Holdings Corp. | 74.50M | 2.04% | 212,439 | 20.70M |
| 398 | ANVS | Annovis Bio, Inc. | 74.02M | -2.79% | 953,632 | - |
| 399 | HRTX | Heron Therapeutics, Inc. | 73.31M | 1.39% | 3,371,102 | 150.71M |
| 400 | PLRX | Pliant Therapeutics, Inc. | 73.07M | -0.84% | 303,540 | - |
| 401 | XBIT | XBiotech Inc. | 72.26M | 0.85% | 40,472 | - |
| 402 | CING | Cingulate Inc. | 67.97M | 8.02% | 720,558 | - |
| 403 | MNOV | MediciNova, Inc. | 65.96M | 2.29% | 17,385 | 596.64K |
| 404 | BYSI | BeyondSpring Inc. | 65.38M | -0.63% | 14,163 | 1.88M |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 65.06M | 2.01% | 208,680 | - |
| 406 | IMA | ImageneBio, Inc. | 64.18M | 4.40% | 7,385 | 800.00K |
| 407 | MCRB | Seres Therapeutics, Inc. | 62.56M | 8.21% | 125,761 | 1.15M |
| 408 | IBO | Impact BioMedical Inc. | 62.21M | 5.74% | 44,382 | 39.00K |
| 409 | EDSA | Edesa Biotech, Inc. | 61.13M | 9.73% | 223,862 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 60.83M | 3.39% | 22,809 | - |
| 411 | ENTX | Entera Bio Ltd. | 59.07M | 1.69% | 29,433 | 42.00K |
| 412 | TCRX | TScan Therapeutics, Inc. | 58.81M | 6.11% | 555,677 | 9.14M |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 58.66M | 1.85% | 200,353 | - |
| 414 | FLNA | Filana Therapeutics, Inc. | 58.45M | -0.82% | 309,129 | - |
| 415 | IBIO | iBio, Inc. | 57.83M | 3.23% | 1,671,168 | 300.00K |
| 416 | ELOX | Eloxx Pharmaceuticals, Inc. | 56.51M | 9.80% | 43,697 | - |
| 417 | CNTX | Context Therapeutics Inc. | 55.13M | -7.73% | 7,475,759 | - |
| 418 | EXOZ | eXoZymes, Inc. | 53.67M | -14.69% | 17,961 | -700.00 |
| 419 | KALA | KALA BIO, Inc. | 52.89M | -9.39% | 143,213 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 52.35M | 6.06% | 99,671 | 53.48M |
| 421 | TIL | Instil Bio, Inc. | 51.27M | -0.66% | 22,001 | - |
| 422 | PDSB | PDS Biotechnology Corporation | 50.74M | -5.31% | 659,811 | - |
| 423 | HYPD | Hyperion DeFi, Inc. | 50.15M | 8.95% | 2,969,669 | 1.04M |
| 424 | RADX | Radiopharm Theranostics Limited | 50.11M | 0.11% | 17,633 | 10.86M |
| 425 | IMMP | Immutep Limited | 50.01M | 4.97% | 349,309 | 5.28M |
| 426 | DWTX | Dogwood Therapeutics, Inc. | 49.77M | -0.67% | 511,942 | - |
| 427 | LTRN | Lantern Pharma Inc. | 49.63M | -0.51% | 257,784 | - |
| 428 | MREO | Mereo BioPharma Group plc | 49.48M | 6.16% | 3,262,232 | 500.00K |
| 429 | ACTU | Actuate Therapeutics, Inc. | 49.05M | 0.99% | 73,847 | - |
| 430 | VERU | Veru Inc. | 47.99M | -4.47% | 280,496 | 16.89M |
| 431 | ATYR | aTyr Pharma, Inc. | 45.39M | 3.37% | 1,582,928 | 190.00K |
| 432 | MGX | Metagenomi Therapeutics, Inc. | 44.42M | 3.51% | 100,093 | 22.33M |
| 433 | ESLA | Estrella Immunopharma, Inc. | 43.46M | 1.00% | 12,278 | - |
| 434 | GNTA | Genenta Science S.p.A. | 43.41M | -1.60% | 127,831 | - |
| 435 | TELO | Telomir Pharmaceuticals, Inc. | 42.98M | -2.34% | 115,540 | - |
| 436 | GOSS | Gossamer Bio, Inc. | 42.01M | 6.74% | 23,153,055 | 55.54M |
| 437 | TVGN | Tevogen Bio Holdings Inc. | 40.62M | 6.01% | 12,665 | - |
| 438 | RNXT | RenovoRx, Inc. | 40.17M | 1.26% | 137,997 | 1.49M |
| 439 | NTRB | Nutriband Inc. | 37.20M | -7.55% | 6,006 | 1.80M |
| 440 | CRVO | CervoMed Inc. | 35.28M | -15.71% | 5,254,816 | 2.09M |
| 441 | INMB | INmune Bio Inc. | 34.56M | 1.56% | 252,948 | 50.00K |
| 442 | ABVC | ABVC BioPharma, Inc. | 34.37M | 5.43% | 102,931 | 797.92K |
| 443 | GRCE | Grace Therapeutics, Inc. | 34.35M | - | 169,319 | - |
| 444 | ALGS | Aligos Therapeutics, Inc. | 33.11M | 7.21% | 156,042 | 4.71M |
| 445 | GRDX | GridAI Technologies Corp. | 32.93M | -2.75% | 73,911 | - |
| 446 | LSTA | Lisata Therapeutics, Inc. | 32.05M | 0.86% | 13,905 | 170.00K |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 32.00M | 4.08% | 149,626 | 90.00K |
| 448 | BOLD | Boundless Bio, Inc. | 31.45M | -0.71% | 64,978 | - |
| 449 | LITS | Lite Strategy, Inc. | 31.28M | -0.09% | 814,570 | - |
| 450 | DARE | Daré Bioscience, Inc. | 31.16M | -1.42% | 133,271 | 1.16M |
| 451 | DYAI | Dyadic International, Inc. | 30.92M | 8.91% | 168,417 | 3.81M |
| 452 | APLM | Apollomics, Inc. | 30.66M | -3.66% | 8,089 | 8.84M |
| 453 | NNVC | NanoViricides, Inc. | 30.53M | -1.47% | 119,894 | - |
| 454 | PSTV | Plus Therapeutics, Inc. | 29.67M | -5.69% | 177,794 | 5.18M |
| 455 | SNTI | Senti Biosciences Holdings, Inc. | 29.61M | 2.24% | 111,788 | 38.00K |
| 456 | SER | Serina Therapeutics, Inc. | 29.50M | -2.94% | 98,688 | 130.00K |
| 457 | BRNS | Barinthus Biotherapeutics plc | 28.53M | -0.13% | 10,194 | 14.97M |
| 458 | KYNB | Kyntra Bio, Inc. | 27.97M | - | 8,445 | 7.44M |
| 459 | EVAX | Evaxion A/S | 27.69M | -2.92% | 31,310 | 7.53M |
| 460 | VTGN | Vistagen Therapeutics, Inc. | 27.34M | - | 2,043,303 | 789.00K |
| 461 | IGC | IGC Pharma, Inc. | 27.24M | -0.68% | 1,067,595 | 1.11M |
| 462 | LGVN | Longeveron Inc. | 26.16M | 9.09% | 312,002 | 1.22M |
| 463 | QNTM | Quantum BioPharma Ltd. | 26.04M | 9.07% | 245,522 | - |
| 464 | SKYE | Skye Bioscience, Inc. | 24.99M | -0.96% | 78,347 | - |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 24.92M | 0.86% | 324,674 | - |
| 466 | PLRZ | Polyrizon Ltd. | 24.76M | 15.55% | 95,523 | - |
| 467 | BCTX | BriaCell Therapeutics Corp. | 24.50M | -1.06% | 66,937 | - |
| 468 | PLUR | Pluri Inc. | 24.28M | - | 8,609 | 1.08M |
| 469 | TVRD | Tvardi Therapeutics, Inc. | 24.20M | -1.90% | 67,789 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 23.29M | 0.70% | 15,539 | -13.27K |
| 471 | CELU | Celularity Inc. | 23.06M | 8.10% | 180,656 | 26.55M |
| 472 | MRKR | Marker Therapeutics, Inc. | 22.51M | - | 33,473 | 3.55M |
| 473 | FTH | Faeth Therapeutics, Inc. | 22.34M | 14.59% | 166,959 | - |
| 474 | VYNE | VYNE Therapeutics Inc. | 21.03M | -0.28% | 25,493 | 454.00K |
| 475 | PTN | Palatin Technologies, Inc. | 21.01M | 3.20% | 3,068 | 12.88M |
| 476 | ALLR | Allarity Therapeutics, Inc. | 20.72M | -6.29% | 190,860 | 345.00K |
| 477 | CLRB | Cellectar Biosciences, Inc. | 19.82M | 1.22% | 101,125 | - |
| 478 | LPCN | Lipocine Inc. | 19.29M | 1.74% | 159,254 | 2.00M |
| 479 | LNAI | Lunai Bioworks Inc. | 18.14M | 40.60% | 26,485,416 | 20.94K |
| 480 | TPST | Tempest Therapeutics, Inc. | 17.93M | - | 58,606 | - |
| 481 | AEON | AEON Biopharma, Inc. | 17.72M | 0.48% | 27,015 | - |
| 482 | PASG | Passage Bio, Inc. | 17.10M | -3.09% | 20,629 | - |
| 483 | ATOS | Atossa Therapeutics, Inc. | 17.09M | -10.59% | 696,590 | - |
| 484 | NCEL | NewcelX Ltd. | 16.96M | -1.87% | 16,340 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 16.78M | -1.51% | 245,767 | - |
| 486 | HOWL | Werewolf Therapeutics, Inc. | 16.72M | -4.44% | 2,034,060 | 1.14M |
| 487 | GTBP | GT Biopharma, Inc. | 16.55M | 2.98% | 1,029,392 | - |
| 488 | CRIS | Curis, Inc. | 16.23M | 6.84% | 4,236,625 | 7.06M |
| 489 | MLEC | Moolec Science SA | 16.14M | -1.27% | 6,440 | 7.83M |
| 490 | CVM | CEL-SCI Corporation | 15.94M | 8.91% | 684,505 | - |
| 491 | HIND | Vyome Holdings, Inc. | 15.30M | -0.91% | 29,215 | 152.72K |
| 492 | LEXX | Lexaria Bioscience Corp. | 15.13M | 3.65% | 62,959 | 368.00K |
| 493 | MBRX | Moleculin Biotech, Inc. | 14.94M | 3.70% | 337,098 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 14.82M | -0.31% | 191,871 | 5.61M |
| 495 | QNCX | Quince Therapeutics, Inc. | 14.72M | 0.30% | 290,414 | - |
| 496 | INAB | IN8bio, Inc. | 14.48M | 6.52% | 22,546 | - |
| 497 | AKTX | Akari Therapeutics, Plc | 13.74M | -7.69% | 120,843 | - |
| 498 | XCUR | Exicure, Inc. | 13.70M | -0.92% | 19,611 | 500.00K |
| 499 | BIVI | BioVie Inc. | 13.50M | 0.56% | 157,948 | - |
| 500 | OSRH | OSR Holdings, Inc. | 13.49M | 2.86% | 561,950 | 2.63M |